Monocytes-macrophages and cytokines/chemokines in fine-needle aspiration biopsy cultures: Enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients

Transplantation

Volumn 63, Issue 12, 1997, Pages 1751-1756

  Oliveira, José G G ^a,b   Xavier, Paula ^a   Neto, Sandra ^a   Mendes, Armando A ^a   Guerra, Levi E R ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b NONE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIGEN; AZATHIOPRINE; CD14 ANTIGEN; CHEMOKINE; COLONY STIMULATING FACTOR 1; CREATININE; CYCLOSPORIN; CYTOKINE; GROWTH FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; OKT 3; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; ARTICLE; ASPIRATION BIOPSY; DOWN REGULATION; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; SIALOGLYCOPROTEINS;

EID: 0030974773     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706270-00008     Document Type: Article

References (37)

1. Atkins RC, Holdsworth SR, Glasgow EF, Matthews FE. The macrophage in human rapidly progressive glomerulonephritis. Lancet 1976; 1: 830.
2. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC. Macrophages in renal injury. Kidney Int 1994; 45 (suppl): S79.
3. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069.
4. Solez K, Racusen LC, Marcussen N, et al. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058.
5. Rabl H, Khoschsorur G, Colombo T, et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int 1993; 43: 912.
6. Kooijmans-Coutinho MF, Hermans J, Schrama E, et al. Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts. Transplantation 1996; 61: 1338.
7. Dooper IM, Bogman MJ, Hoitsma AJ, Maass CN, Assmann KJ, Koene RA. Detection of interstitial increase in macrophages, characteristic of acute interstitial rejection, in routinely processed renal allograft biopsies using the monoclonal antibody KP1. Transpl Int 1992; 5: 209.
8. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547.
9. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757.
10. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993; 11: 29.
11. Wenzel UO, Abboud HE. Chemokines and renal disease. Am J Kidney Dis 1995; 26: 982.
12. + subpopulation. Immunol Today 1996; 17: 424.
13. Sharma VK, Bologa RM, Xu G-P, et al. Intragraft TGF-β1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297.
14. Brady HR, Serhan CN. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity. Curr Opin Nephrol Hypertens 1996; 5: 20.
15. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113.
16. Tam FWK, Karkar AM, Smith J, et al. Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int 1996; 49: 715.
17. Haÿry P. Fine-needle aspiration biopsy in renal transplantation. Kidney Int 1989; 36: 130.
18. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
19. Haÿry P, Von Willebrand E: Practical guidelines for fine needle aspiration biopsy of human renal allografts. Ann Clin Res 1981; 13: 288.
20. van Voorhis WC, Steinman RM, Hair LS, et al. Specific antimononuclear phagocyte monoclonal antibodies. J Exp Med 1983; 158: 126.
21. Dooper IMM, Hoitsma AJ, Maass CN, et al. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection. Transplantation 1994; 58: 820.
22. Raftery MJ, Seron D, Koffman G, Hartley B, Janossy G, Cameron JS. The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantation 1989; 48: 238.
23. Volpes R, van den Oord JJ, van Damme B, Desmet V. CD14 as marker for allograft liver rejection? Lancet 1991; 337: 60.
24. Atkins RC. Interleukin-1 in crescentic glomerulonephritis. Kidney Int 1995; 48: 576.
25. Le Meur Y, Fixe P, Aldigier JC, Leroux-Robert C, Praloran V. Macrophage colony stimulating factor involvement in uremic patients. Kidney Int 1996; 50: 1007.
26. Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL. In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992; 41: 191.
27. Kimball PM, Radovancevíc B, Isom T, Spickard A, Frazier OH. The paradox of cytokine monitoring: predictor of immunologic activity as well as immunologic silence following cardiac transplantation. Transplantation 1996; 61: 909.
28. Oliveira G, Xavier P, Murphy B, et al. Cytokine analysis of human renal allograft aspiration biopsies predicts acute rejection [Abstract]. J Am Soc Nephrol 1996; 7: 1918.
29. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106.
30. Williams JM, DeLoria D, Hansen JA, et al. The events of primary T cell activation can be staged by use of sepharose-bound anti-T3(64.1) monoclonal antibody and purified interleukin-1. J Immunol 1985; 135: 2249.
31. Abbott F, Ryan JJ, Ceska M, Matsushima K, Sarraf CE, Rees AJ. Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukin-6 and -8. Kidney Int 1991; 40: 597.
32. Seventer GAV, Shimizu Y, Horgan KJ, Luce GEG, Webb D, Shaw S. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Eur J Immunol 1991; 21: 1711.
33. Kerr PG, Nikolic-Paterson DJ, Lan HY, Rainone S, Tesch G, Atkins RC. Deoxyspergualin suppresses local macrophage proliferation in renal allograft rejection. Transplantation 1994; 58: 596.
34. Mannon RB, Sundar SK, Sanfilippo FP, Coffman TM. Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. Transplantation 1993; 56: 1157.
35. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein a (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med 1993; 177: 1821.
36. Safirstein R, Megyesi J, Saggi SJ, et al. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: F1095.
37. Kutukculer N, Clark K, Rigg KM, et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995; 59: 333.